FDAnews
www.fdanews.com/articles/139432-adaptive-design-saves-time-money-but-use-in-late-stage-trials-still-risky

Adaptive Design Saves Time, Money But Use in Late Stage Trials Still Risky

August 22, 2011
Adaptive design can save R&D time and money by allowing clinical researchers to terminate a trial early if the desired outcome appears unlikely, a new report says.
Clinical Trials Advisor